View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 21, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 14, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 12, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Molina Healthcare, Inc.: Elevated medical cost trends and adverse rate...

Molina’s results weakened amid elevated medical costs, but strong capital, Medicaid scale, and embedded earnings support credit quality despite continued margin pressure into 2026 outlook.

Moody's Ratings assigned Ba2 rating to Molina Healthcare's new senior ...

Moody's Ratings assigned Ba2 rating to Molina. Healthcare's new senior unsecured debt. New York, November 17, 2025-- Moody's Ratings has assigned a Ba2 rating to the new.

Molina Healthcare Inc: 1 director

A director at Molina Healthcare Inc bought 10,000 shares at 155.937USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Moody’s Ratings assigns a Ba2 rating to Molina’s new senior unsecured ...

New York , November 13, 2024 – Moody's Ratings (Moody's) has assigned a Ba2 rating to the new issuance of senior unsecured debt of Molina Healthcare, Inc. (Molina, NYSE: MOH). We anticipate the issuance, a private placement, to total $500 million and mature in 2033. The purpose is for general corpor...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 05 17

Cash bond markets are overstating MOH's credit risk with a YTW of 6.140% relative to an Intrinsic YTW of 5.170%, while CDS markets are accurately stating credit risk with a CDS of 112bps relative to an Intrinsic CDS of 81bps. Furthermore, Moody's is materially overstating MOH's fundamental credit risk with its highly speculative Ba2 credit rating seven notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As a...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 02 27

Cash bond markets are overstating MOH's credit risk with a YTW of 6.033% relative to an Intrinsic YTW of 5.103%, while CDS markets are slightly overstating credit risk with a CDS of 152bps relative to an Intrinsic CDS of 83bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate BehaviorTM analysis highlights mostly negative signals for credit holders. As a...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2024 01 17

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 01 09

Credit markets are overstating MOH's credit risk with a YTW of 5.895% and a CDS of 143bps, relative to an Intrinsic YTW of 4.665% and an Intrinsic CDS of 76bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As a positive, most management members are material owners of MOH equity...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500, Nasdaq 100 Back at Support Our expectations since late September remain unchanged; equities are not yet out of the woods, but as long as the S&P 500 is above 4165-4200, most signs point to this being a normal pullback within the ongoing bullish trend in SPX. Similarly, the Nasdaq 100 (QQQ) is testing support at $350-$355 (the 4-month bull flag/falling wedge pattern). The Russell 2000 is also approaching 1+ year support at 1640. Breakdowns would be our cue to get defensive, as it would ...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 10 11

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 10 09

Cash bond markets are materially overstating MOH's credit risk with a YTW of 7.387% relative to an Intrinsic YTW of 5.587%, while CDS markets are overstating credit risk with a CDS of 176bps relative to an Intrinsic CDS of 78bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As ...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 07 19

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Molina Healthcare, Inc.: Molina’s acquisition of Bright Health's Medic...

The Bright House Medicare acquisition will add to Molina's earnings and provide cost-synergy opportunities.

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 07 03

Cash bond markets are materially overstating MOH's credit risk with a YTW of 6.496% relative to an Intrinsic YTW of 4.816%, while CDS markets are overstating credit risk with a CDS of 194bps relative to an Intrinsic CDS of 85bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. Tha...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2023 04 12

Cash bond markets are materially overstating MOH's credit risk with a YTW of 6.138% relative to an Intrinsic YTW of 4.428%, while CDS markets are overstating credit risk with a CDS of 195bps relative to an Intrinsic CDS of 91bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. Tha...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2022 12 28

Valens Credit Research team highlights MOH, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch